Home Critical comments to a recent EFLM recommendation for the review of reference intervals
Article
Licensed
Unlicensed Requires Authentication

Critical comments to a recent EFLM recommendation for the review of reference intervals

  • Rainer Haeckel EMAIL logo , Werner Wosniok , Farhad Arzideh , Jakob Zierk , Eberhard Gurr and Thomas Streichert
Published/Copyright: February 2, 2017

Abstract

In a recent EFLM recommendation on reference intervals by Henny et al., the direct approach for determining reference intervals was proposed as the only presently accepted “gold” standard. Some essential drawbacks of the direct approach were not sufficiently emphasized, such as unacceptably wide confidence limits due to the limited number of observations claimed and the practical usability for only a limited age range. Indirect procedures avoid these disadvantages of the direct approach. Furthermore, indirect approaches are well suited for reference limits with large variations during lifetime and for common reference limits.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Appendix

Calculating the confidence limits of a given reference limit (RL) is most effectively done using the distribution of the reference values. Also, the 100%·(1–p) reference limits RL1 and RL2 themselves can be obtained from this distribution. They are defined as the p/2 and 1–p/2 quantiles of the reference value distribution with distribution function F:

RL1=F1(p/2)

RL2=F1(1p/2)

For an underlying normal distribution with mean μ and standard deviation σ, the limits of a 95% reference interval (p=0.05) are μ±1.96 σ. In general, e.g. for the log-normal distribution, the RLs are calculated from the inverse distribution function F−1 (the quantile function). This is available in standard software packages.

Confidence limits for a reference limit RL are calculated according to Serfling [31] using the standard deviation of the calculated RL given by

sRL=p(1p)nf(RL)

where 1–p is the confidence level of the confidence interval, n is the number of reference values that were used to determine the RL, and f(RL) is the probability density function f calculated at RL. Using this standard deviation, the 100%·(1–α) confidence interval is given by

CI=(RLz1α2sRL,RL+z1α2sRL)

where z1−α/2 is the 1−α/2 quantile of the standard normal distribution (for α=0.05: z1−α/2=1.96). The preceding equation is an asymptotic one, but numerical simulation has shown its validity already for n much smaller than 120.

References

1. Henny J, Vassault A, BoursierG, Vukasovic I, Brguljan PM, Lohmander M, et al. Recommendation for the review of biological reference intervals in medical laboratories. Clin Chem Lab Med 2016;54:1893–900.10.1515/cclm-2016-0793Search in Google Scholar PubMed

2. Tate JR, Jones GR. Transference and validation of reference intervals. Clin Chem 2015;61:1012–5.10.1373/clinchem.2015.243055Search in Google Scholar PubMed

3. Stachon A. Prostate-specific antigen: significance for the diagnosis of prostate cancer in geriatric patients. J Lab Med 2007;31:8–14.Search in Google Scholar

4. Haeckel R, Wosniok W. Observed, unknown distributions of clinical chemical quantities should be considered to be log-normal: a proposal. Clin Chem Lab Med 2010;48:1393–6.10.1515/CCLM.2010.273Search in Google Scholar PubMed

5. Solberg HE. Approved recommendation (1987) on the theory of reference values. J Clin Chem Clin Biochem 1987;25:645–56.Search in Google Scholar

6. CLSI/IFCC. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline – third edition. CLSI document C28-P3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008;28:1–50.Search in Google Scholar

7. Haeckel R, Wosniok W. A new concept to desire permissible limits for analytical imprecision and bias consistency diagnostic requirements and state-of-the-art. Clin Chem Lab Med 2011,49:623–35.10.1515/CCLM.2011.116Search in Google Scholar PubMed

8. Battacharya CG. A simple method of resolution of a distribution into Gaussian components. Biometrics 1967;23:115–35.10.2307/2528285Search in Google Scholar

9. Naus AJ, Borst A, Kuppens PS. The use of patient data for the calculation of reference values for some haematological parameters. J Clin Chem Clin Biochem 1980;18:621–5.10.1515/cclm.1980.18.10.621Search in Google Scholar PubMed

10. Baadenhuijsen H, Smit JC. Indirect estimation of clinical chemistry reference intervals from total hospital patient data: application of a modified Bhattacharaya procedure. J Clin Chem Clin Biochem 1985;23:829–39.Search in Google Scholar

11. Karisto V, Hänninen KP, Leino A, Pulkki K, Peltola O, NäniÖ V, et al. Generation of reference values for cardiac enzymes from hospital admission laboratory data. Eur J Clin Chem Clin Biochem 1994;27:789–96.10.1515/cclm.1994.32.10.789Search in Google Scholar PubMed

12. Martin HF, Hologgitas JV, Drisoll J, Fanger H, Gudzinowicz BJ. Reference values based on populations accessible to hospitals. In: Gräsbeck R, Alström T, editors. Reference values in laboratory medicine. Chichester: Wiley, 1981:233–62.Search in Google Scholar

13. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results; is there a better way? Am J Clin Pathol 2010;133:175–7.10.1309/AJCPN5BMTSF1CDYPSearch in Google Scholar PubMed

14. Reference limit estimator. Available at: www.dgkl.de/PA106975_ENDE_VAR100. Accessed 15 Dec 2016.Search in Google Scholar

15. Arzideh F, Wosniok W, Gurr E, Hinsch W, Schumann G, Weinstock N, et al. A plea for intra-laboratory refrence limits. Part 2. A bimodal retrospective concept for determining reference limits from intra-laboratory data bases demonstrated by catalytic activity concentrations of enzymes. Clin Chem Lab Med 2007:45:1043–57. (Kombinationsmodell, AG der DGKL).10.1515/CCLM.2007.250Search in Google Scholar PubMed

16. Hoffmann RG. Statistics in the practice of medicine. J Am Med Assoc 1963;185:864–73.10.1001/jama.1963.03060110068020Search in Google Scholar PubMed

17. Lapin A. Geriatrics: what is normal in the aged? Should we expect a new paradigm shift in laboratory medicine. J Lab Med 2007;31:2–7.Search in Google Scholar

18. Böhmer F. Responsibilities of prevention in gerontology. Wien Med Wochenschr 2001;151:4368–71.Search in Google Scholar

19. Zierk J, Arzideh F, Haeckel R, Rascher W, Rauh M, Metzler M. Indirect determination of pediatric blood count reference intervals. Clin Chem Lab Med 2013;51:863–72.10.1515/cclm-2012-0684Search in Google Scholar

20. Loh TP, Antoniou G, Baghurst P, Metz MP. Development of paediatric biochemistry centile charts as a complement to laboratory reference intervals. Pathology 2014;46: 336–43.10.1097/PAT.0000000000000118Search in Google Scholar

21. Yang Q, Lew HY, Peh RH, Metz MP, Loh TP. An automated and objective method for age partitioning of reference intervals based on continuous centile curves. Pathology 2016;48:581–5.10.1016/j.pathol.2016.07.002Search in Google Scholar

22. Soldin SJ, Brugnara C, Wong EC. Pediatric reference ranges. 4th ed. Washington, DC: AACC Press, 2003.Search in Google Scholar

23. Nilsson-Ehle H, Jagenburg R, Landahl S, Svanborg A. Blood haemoglobin declines in the elderly: implications for reference intervals from age 70 – 88. Eur J Haematol 2000;65:297–305.10.1034/j.1600-0609.2000.065005297.xSearch in Google Scholar

24. Balduini CL, Noris P. Platelet count and aging. Haematologica 2014;99:953–5.10.3324/haematol.2014.106260Search in Google Scholar

25. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chem Acta 2003;334:5–23.10.1016/S0009-8981(03)00133-5Search in Google Scholar

26. Arseneau E, Balion CM. Statistical methods used in the calculation of geriatric reference intervals: a systematic review. Clin Chem Lab Med 2016;54:377–88.10.1515/cclm-2015-0420Search in Google Scholar

27. Zierk J, Arzideh F, Haeckel R, Cario H, Frühwald MC, Groß HJ, et al. Pediatric reference intervals for alkaline phosphatase. Clin Chem Lab Med 2016;55:102–10.10.1515/cclm-2016-0318Search in Google Scholar

28. Haeckel R, Wosniok W, Arzideh F. Proposed classification of various limit values (guide values) used in assisting the interpretation of quantitative laboratory test results. Clin Chem Lab Med 2009;47:494–7.10.1515/CCLM.2009.043Search in Google Scholar

29. Ceriotti F, Henny J. “Are my laboratory results normal?” Considerations to be made concerning reference intervals and decision limits. eIFCC 2008;19. Available at: http://www.ifcc.org.Search in Google Scholar

30. Murphy EA, Abbey H. The normal range – a common misuse. J Chronic Dis 1967;20:79–88.10.1016/0021-9681(67)90099-9Search in Google Scholar

31. Serfling RJ. Approximation theorems of mathematical statistics. New York: John Wiley & Sons, 1980:1–371.10.1002/9780470316481Search in Google Scholar

Received: 2016-12-6
Accepted: 2017-1-2
Published Online: 2017-2-2
Published in Print: 2017-3-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Targeting errors in microbiology: the case of the Gram stain
  4. Time for a holistic approach and standardization education in laboratory medicine
  5. Reviews
  6. Serum uric acid levels and risk of prehypertension: a meta-analysis
  7. Lactic acidosis: an update
  8. Mini Review
  9. Progress and impact of enzyme measurement standardization
  10. Opinion Paper
  11. Critical comments to a recent EFLM recommendation for the review of reference intervals
  12. IFCC Paper
  13. Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project
  14. Genetics and Molecular Diagnostics
  15. Evaluation and comparison of three assays for molecular detection of spinal muscular atrophy
  16. General Clinical Chemistry and Laboratory Medicine
  17. Risk analysis of the preanalytical process based on quality indicators data
  18. Analytical and clinical validation of the new Abbot Architect 25(OH)D assay: fit for purpose?
  19. Looking beyond linear regression and Bland-Altman plots: a comparison of the clinical performance of 25-hydroxyvitamin D tests
  20. Next-generation osmotic gradient ektacytometry for the diagnosis of hereditary spherocytosis: interlaboratory method validation and experience
  21. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS
  22. Monitoring nicotine intake from e-cigarettes: measurement of parent drug and metabolites in oral fluid and plasma
  23. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool
  24. A real-world evidence-based approach to laboratory reorganization using e-Valuate benchmarking data
  25. Cancer Diagnostics
  26. Utility of proGRP as a tumor marker in the medullary thyroid carcinoma
  27. Cardiovascular Diseases
  28. Can non-cholesterol sterols and lipoprotein subclasses distribution predict different patterns of cholesterol metabolism and statin therapy response?
  29. Infectious Diseases
  30. Improving Gram stain proficiency in hospital and satellite laboratories that do not have microbiology
  31. Diabetes
  32. Volumetric absorptive microsampling at home as an alternative tool for the monitoring of HbA1c in diabetes patients
  33. Corrigendum
  34. EFLM Recommendation
  35. Corrigendum to: Recommendation for the review of biological reference intervals in medical laboratories
  36. Letters to the Editor
  37. Evaluation of the trueness of serum alkaline phosphatase measurement in a group of Italian laboratories
  38. Innovative software for recording preanalytical errors in accord with the IFCC quality indicators
  39. Mixing studies for abnormal coagulation screen – the current trend
  40. Identification of 5-fluorocytosine as a new interfering compound in serum capillary zone electrophoresis
  41. How to define reference intervals to rule in healthy individuals for clinical trials?
  42. Evaluation of the performance of INDEXOR® in the archive unit of a clinical laboratory: a step to Lean laboratory
  43. Evaluation of an automated chemiluminescent immunoassay for salivary cortisol measurement. Utility in the diagnosis of Cushing’s syndrome
  44. Analysis of hemolysis, icterus and lipemia in arterial blood gas specimens
  45. Comparison of three routine insulin immunoassays: implications for assessment of insulin sensitivity and response
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2016-1112/html
Scroll to top button